State news

Conn. selects provider for seed-to-sale tracking of cannabis

The Connecticut Department of Consumer Protection Drug Control Division has selected The Consultants Consortium and their partner, Forian, for its Bio-track inventory tracking system to monitor the movement of cannabis products in the state’s medical and adult-use cannabis markets. The System will provide a real-time inventory of cannabis products available in the state and to prevent unlawful diversion of products.

Commissioner Michelle Seagull says being able to track the state’s cannabis inventory from seed to sale will allow the department to monitor cannabis production and inventory as it moves from the earliest phases of growth to when it reaches the qualifying patient or consumer.   She added that this information will allow the Department to see what is currently available in both markets, project future inventory, and identify any potential diversion in the markets.

The Biotrack software, commonly referred to as seed-to-sale tracking, will track the cannabis from when it is first planted as a seed or clone to the point of sale to the consumer. All licensed medical marijuana and adult-use cannabis establishments will be required to participate in the tracking system and log movement of cannabis as it is grown, manufactured into other products, packaged, tested, and sold to qualifying patients or consumers.

Information collected by the system will be used by the Department of Consumer Protection and the Department of Revenue Services, and will be made available to other entities, including law enforcement, as required by law.

Cannabis was approved for adult-use in June 2021. Adult-use cannabis retail sales are anticipated to begin in the state by the end of 2022.

Now Playing

Rock Facebook




Artist Profile

Concert Calendar

Community Calendar